GlaxoSmithKline PLC: Total Voting Rights | Company Announcements

Tuesday 02 February, 2010

GlaxoSmithKline PLC

Total Voting Rights

RNS Number : 5319G

GlaxoSmithKline PLC

02 February 2010

Total Voting Rights and Capital

In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc ("the Company") hereby notifies the market of the following:

The Company's issued share capital as at 31 January 2010 consisted of 5,665,502,017 Ordinary shares of 25p each with voting rights, of which 474,194,158 Ordinary shares are held in Treasury.

Therefore, the total number of voting rights in the Company is 5,191,307,859. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.

S M Bicknell

Company Secretary

2 February 2010

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRUGUPPPUPUGGP

Investegate takes no responsibility for the accuracy of the information within the site.

The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.